文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

血色病。

Haemochromatosis.

机构信息

Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.

Medical School, University of Western Australia, Perth, WA, Australia.

出版信息

Lancet. 2023 May 27;401(10390):1811-1821. doi: 10.1016/S0140-6736(23)00287-8. Epub 2023 Apr 27.


DOI:10.1016/S0140-6736(23)00287-8
PMID:37121243
Abstract

Haemochromatosis is one of the most common genetic diseases affecting patients of northern European ancestry. It is overdiagnosed in patients without iron overload and is underdiagnosed in many patients. Early diagnosis by genetic testing and therapy by periodic phlebotomy can prevent the most serious complications, which include liver cirrhosis, liver cancer, and death. This Seminar includes an update on the origins of haemochromatosis; and an overview pathophysiology, genetics, natural history, signs and symptoms, differential diagnoses, treatment with phlebotomy, outcomes, and future directions.

摘要

血色病是影响北欧血统患者的最常见遗传疾病之一。在没有铁过载的患者中过度诊断,而在许多患者中则诊断不足。通过基因检测进行早期诊断和定期放血治疗可以预防最严重的并发症,包括肝硬化、肝癌和死亡。本研讨会包括血色病起源的最新信息;以及病理生理学、遗传学、自然病史、体征和症状、鉴别诊断、放血治疗、结果和未来方向的概述。

相似文献

[1]
Haemochromatosis.

Lancet. 2023-5-27

[2]
Genetic haemochromatosis: diagnosis and treatment of an iron overload disorder.

Nurs Stand. 2022-11-2

[3]
EASL Clinical Practice Guidelines on haemochromatosis.

J Hepatol. 2022-8

[4]
[Genetic iron overloads and hepatic insulin-resistance iron overload syndrome: an update].

Rev Med Interne. 2009-1

[5]
[Diagnosis of iron overload syndrome].

Eksp Klin Gastroenterol. 2010

[6]
Hereditary haemochromatosis: detection and management.

Med J Aust. 2001-10-15

[7]
Diagnosis and management of genetic haemochromatosis.

Best Pract Res Clin Haematol. 2002-6

[8]
[Diagnosis of 5 patients with possible primary hemochromatosis].

Ned Tijdschr Geneeskd. 2003-4-5

[9]
Haemochromatosis: a clinical update for the practising physician.

Intern Med J. 2018-5

[10]
Review article: the screening, diagnosis and optimal management of haemochromatosis.

Aliment Pharmacol Ther. 1997-8

引用本文的文献

[1]
Natural Products as Modulators of Iron Metabolism and Ferroptosis in Diabetes and Its Complications.

Nutrients. 2025-8-21

[2]
Iron metabolism and ferroptosis in human health and disease.

BMC Biol. 2025-8-22

[3]
Diagnosis and Treatment of HFE-Linked Hemochromatosis.

Adv Exp Med Biol. 2025

[4]
FRRS1L variants and ferriheme overload drive hyperpigmentation and systemic Iron overload in lanping black bone sheep.

Cell Biosci. 2025-6-24

[5]
Iron and the immune system.

Nat Rev Immunol. 2025-6-16

[6]
Reference diagnosis and treatment process of juvenile hemochromatosis patients.

World J Clin Cases. 2025-5-26

[7]
A phase 1b randomised clinical trial evaluating BBI-001, a non-absorbed oral therapeutic for the treatment of iron overload.

Sci Rep. 2025-5-17

[8]
Iron overload is not the same everywhere: Particularities of iron-metabolism gene mutations in Brazil and a proposal for the investigation and management of iron overload in this population.

Hematol Transfus Cell Ther. 2025

[9]
Association of genotypes with hemochromatosis-related phenotypes in the All of Us research program.

Genet Med Open. 2025-1-7

[10]
Studies of Slc30a10 Deficiency in Mice Reveal That Intestinal Iron Transporters Dmt1 and Ferroportin Transport Manganese.

Cell Mol Gastroenterol Hepatol. 2025

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索